TIDMCEL 
 
RNS Number : 4502Y 
Celsis International PLC 
03 September 2009 
 

Not for release, publication or distribution in whole or in part in or into or 
from the United States, Canada, Australia or Japan or any other jurisdiction 
where it is unlawful to do so. 
 
 
 
 
Recommended all cash offer 
 
 
for 
 
 
CELSIS INTERNATIONAL PLC 
 
 
by 
 
 
KBC PEEL HUNT LTD 
 
 
on behalf of 
 
 
NASTOR INVESTMENTS LIMITED 
 
 
Offer Declared Unconditional in All Respects 
 
 
 
 
It was announced on 3 August 2009 that the boards of Nastor Investments Limited 
("Nastor Investments") and Celsis International Plc ("Celsis") had reached 
agreement on the terms of a recommended all cash offer to be made by Nastor 
Investments to acquire the entire issued and to be issued share capital of 
Celsis not already owned by the NAV Funds. The document setting out the full 
terms and conditions of the Offer was posted to Celsis Shareholders on 10 August 
2009. 
 
The board of Nastor Investments is pleased to announce that the Offer for Celsis 
has now been declared unconditional in all respects. As at 1.00 p.m. on 2 
September 2009, Nastor Investments either owned or had received valid 
acceptances in respect of, in aggregate, 15,047,923 Celsis Shares, carrying 
approximately 68.74 per cent. of voting rights attached to the existing issued 
share capital of Celsis. 
 
 
Acceptance Levels 
 
The board of Nastor Investments is pleased to announce that, as at 1.00 p.m. 
(London time) on 2 September 2009, being the First Closing Date of the Offer, 
valid acceptances of the Offer had been received in respect of 9,749,401 
Celsis Shares, representing approximately 44.53 per cent. of the existing issued 
share capital of Celsis. 
 
This total includes valid acceptances in respect of: 
 
 
(a)2,807,719 Celsis Shares, representing approximately 12.8 per cent of the 
existing issued share capital of Celsis, for which Nastor Investments had 
received irrevocable undertakings to accept the Offer (including from the Celsis 
Directors in respect of 219,335 Celsis Shares, in aggregate, representing 
approximately 1.0 per cent. of the existing issued share capital of Celsis); and 
 
 
 (b)1,336,150 Celsis Shares, representing approximately 6.1 per cent. of the 
existing issued share capital of Celsis, for which Nastor Investments had 
received non-binding letters of intent to accept the Offer. 
 
 
Further details of the terms of the irrevocable undertakings and letters of 
intent are set out in the Offer Document. 
In addition to the acceptances referred to above, Nastor Investments has 
acquired, in aggregate, 947,629 Celsis Shares, representing approximately 4.3 
per cent. of the existing issued share capital of Celsis in the market at the 
Offer Price since the Offer Document was posted on 10 August 2009. Nastor 
Investments has acquired the Celsis Shares held by the NAV Funds, comprising in 
aggregate 4,350,893 Celsis Shares, representing approximately 19.9 per cent of 
the existing issued share capital of Celsis. 
Accordingly, as at 1.00 p.m. on 2 September 2009, Nastor Investments either 
owned or had agreed to acquire or had received valid acceptances in respect of, 
in aggregate, 15,047,923 Celsis Shares, carrying approximately 68.74 per cent of 
voting rights attached to the existing issued share capital of Celsis. 
Nastor Investments is therefore pleased to announce that the 50 per cent. 
acceptance condition, details of which are set out in Part A to Appendix I of 
the Offer Document, has been satisfied and that the Offer has now become 
unconditional as to acceptances. 
 
 
All the other conditions to the Offer have now been satisfied or waived and the 
Offer has therefore been declared unconditional in all respects. 
 
 
Cancellation of Listing and Compulsory Acquisition 
 
 
As stated in the Offer Document, provided that Nastor Investments has acquired 
or agreed to acquire 75 per cent. of the voting rights attached to the Celsis 
Shares, Nastor Investments intends to procure the making of an application by 
Celsis for the cancellation of the listing of Celsis Shares on the Official List 
and the admission to trading of Celsis Shares on the London Stock Exchange in 
accordance with the Listing Rules and the rules of the London Stock Exchange. It 
is anticipated that should such an application be made, cancellation of the 
Celsis listing and admission to trading (together "delisting") will take effect 
either: (i) no earlier than 20 Business Days after Nastor Investments announces 
that it has, by virtue of its shareholdings in Celsis and valid acceptances of 
the Offer, acquired or agreed to acquire Celsis Shares carrying at least 75 per 
cent. of the voting rights of Celsis or (ii) no earlier than 20 Business Days 
after Celsis Shareholders approve the delisting in general meeting. Following 
delisting, Nastor Investments also intends that Celsis be converted into a 
private limited company. 
 
The delisting of Celsis Shares will significantly reduce the liquidity and 
marketability of any Celsis Shares not assented to the Offer at that time. In 
this event there may be no future market for Celsis Shareholders to realise 
their investment in Celsis. There is no guarantee that any dividends or other 
distributions would be made by Celsis and therefore Celsis Shareholders may not 
receive any return from their investment. 
 
 
Nastor Investments also confirms that provided sufficient valid acceptances of 
the Offer are received, it intends to exercise its rights pursuant to the 
provisions of Chapter 3 of Part 28 of the 2006 Act to acquire compulsorily the 
remaining Celsis Shares in respect of which the Offer has not been accepted. 
 
 
Resignations and Appointments 
 
 
As the Offer has been declared wholly unconditional, the resignations of Jack 
Rowell, Christopher Evans and Jeremy Barnes have become effective. Christopher 
Mills and Jeremy Brade have been appointed and will join Jay LeCoque and 
Christian Madrolle on the Board with immediate effect. 
 
 
Extension of the Offer 
 
 
The Offer, which remains subject to the terms and conditions set out in the 
Offer Document, is being extended and will remain open for acceptance until 
further notice. Not less than 14 days' notice in writing of the closing of the 
Offer will be given to Celsis Shareholders who have not accepted the Offer, that 
the offer will be open for such period before closing it. 
 
 
Settlement 
 
 
Settlement will be effected on or before 17 September 2009 for Celsis 
Shareholders who have validly accepted the Offer prior to today's date. 
 
 
Settlement for Celsis Shareholders who validly accept the Offer hereafter will 
be effected within 14 calendar days of receipt of their valid acceptance. 
 
 
Further details of settlement arrangements in relation to the Offer are set out 
in the Offer Document. 
 
 
To Accept the Offer 
 
 
Acceptance of the Offer by Celsis Shareholders who have not yet accepted the 
Offer and who hold Celsis Shares in certificated form (that is, not in CREST) 
are encouraged to complete, sign and return the Form of Acceptance, together 
with share certificates and/or other documents of title, by hand (during normal 
business hours) or by post to Capita Registrars, Corporate Actions, The 
Registry, 34 Beckenham Road, Beckenham, Kent BR3 4TU as soon as possible. Celsis 
Shareholders who hold Celsis Shares in uncertificated form (that is, in CREST) 
are encouraged to accept the Offer electronically through CREST in accordance 
with the instructions in the Offer Document as soon as possible. 
 
Full details of how to accept the Offer in respect of certificated and 
uncertificated Celsis Shares are set out in the Offer Document and, in the case 
of certificated Celsis Shares, the accompanying Form of Acceptance.  For 
assistance relating to the Offer, please telephone Capita Registrars on 0871 664 
0321 from within the UK or on + 44 20 8639 3399 if calling from outside the UK. 
Calls to the 0871 664 0321 number cost 10 pence per minute from a BT landline. 
Other network providers' costs may vary. Lines are open 9.00 am to 5.00 pm 
(London time) Monday to Friday (except UK public holidays). Calls to the 
helpline from outside the UK will be charged at the applicable international 
rate. Different charges may apply to calls from mobile telephones and calls may 
be recorded and randomly monitored for security and training purposes. The 
helpline cannot provide advice on the merits of the Proposals nor give any 
financial, legal or tax advice. 
 
 
General 
 
 
Terms used in this announcement shall have the meaning given to them in the 
Offer Document dated 10 August 2009, unless the context requires otherwise. 
 
 
In accordance with Rule 19.11 of the City Code, a copy of this announcement will 
be published on the following websites: 
 www.navalue.co.uk/site/literature/NASTOR/ and 
www.celsis.com/about-our-company/news-room/financial-news/2009/. 
 
Copies of the Offer Document and Form of Acceptance will be available from the 
offices of Capita Registrars, Corporate Actions, The Registry, 34 Beckenham 
Road, Beckenham, Kent BR3 4TU. The Offer Document may also be obtained from the 
website of Celsis, www. 
celsis.com/about-our-company/news-room/financial-news/2009/. 
 
 
PRESS ENQUIRIES 
 
 
For further information contact: 
 
 
+-----------------------------------------------+-------------------------------+ 
| Nastor Investments Limited                    | 020 7747 5678                 | 
+-----------------------------------------------+-------------------------------+ 
| Jeremy Brade                                  |                               | 
+-----------------------------------------------+-------------------------------+ 
| Timothy Sturm                                 |                               | 
+-----------------------------------------------+-------------------------------+ 
|                                               |                               | 
+-----------------------------------------------+-------------------------------+ 
| KBC Peel Hunt (Financial Adviser to Nastor    | 020 7418 8900                 | 
| Investments)                                  |                               | 
+-----------------------------------------------+-------------------------------+ 
| Richard Kauffer                               |                               | 
+-----------------------------------------------+-------------------------------+ 
| Daniel Harris                                 |                               | 
| Simon Brown                                   |                               | 
+-----------------------------------------------+-------------------------------+ 
|                                               |                               | 
+-----------------------------------------------+-------------------------------+ 
| Celsis                                        | 020 7831 3133                 | 
+-----------------------------------------------+-------------------------------+ 
| Jay LeCoque                                   |                               | 
+-----------------------------------------------+-------------------------------+ 
| Christian Madrolle                            |                               | 
+-----------------------------------------------+-------------------------------+ 
|                                               |                               | 
+-----------------------------------------------+-------------------------------+ 
| Nomura Code (Financial Adviser to Celsis)     | 020 7776 1200                 | 
+-----------------------------------------------+-------------------------------+ 
| Chris Collins                                 |                               | 
+-----------------------------------------------+-------------------------------+ 
| Phil Walker                                   |                               | 
+-----------------------------------------------+-------------------------------+ 
| Giles Balleny                                 |                               | 
+-----------------------------------------------+-------------------------------+ 
|                                               |                               | 
+-----------------------------------------------+-------------------------------+ 
| Financial Dynamics (PR Adviser to Celsis)     | 020 7831 3133                 | 
+-----------------------------------------------+-------------------------------+ 
| Jonathan Birt                                 |                               | 
+-----------------------------------------------+-------------------------------+ 
| Susan Quigley                                 |                               | 
+-----------------------------------------------+-------------------------------+ 
 
 
KBC Peel Hunt Ltd ("KBC Peel Hunt") which is authorised and regulated by the 
Financial Services Authority in the United Kingdom, is acting for Nastor Holding 
and Nastor Investments and no one else in connection with the Offer and will not 
be responsible to any person other than Nastor Holding and Nastor Investments 
for providing the protections afforded to clients of KBC Peel Hunt or for 
providing advice in relation to the Offer, the content of this announcement or 
any matter referred to herein. 
 
 
Nomura Code Securities Limited ("Nomura Code"), which is authorised and 
regulated by the Financial Services Authority in the United Kingdom, is acting 
for Celsis and no one else in connection with the Offer and will not be 
responsible to any person other than Celsis for providing the protections 
afforded to clients of Nomura Code or for providing advice in relation to the 
Offer, the content of this announcement or any matter referred to herein. 
 
 
This announcement does not constitute, or form part of, any offer for, or any 
solicitation of any offer for, securities. Any response to the Offer should be 
made only on the basis of information referred to in the Offer Document which 
Nastor Investments sent to Celsis Shareholders and, for information only, to 
holders of options under the Celsis Share Schemes on 10 August 2009. 
 
 
The availability of the Offer to persons who are not resident in the United 
Kingdom may be affected by the laws of the relevant jurisdiction in which they 
are located. Such persons should inform themselves of, and observe, any 
applicable legal or regulatory requirements of their jurisdiction. Any failure 
to comply with these requirements may constitute a violation of the securities 
laws at any such jurisdiction. Further details in relation to overseas 
shareholders are contained in the Offer Document. 
 
 
The Offer referred to in this announcement is not being made available directly 
or indirectly, in, into or by use of the mails of, or by any means or 
instrumentality (including, without limitation, telephonically or 
electronically) or interstate or foreign commerce of, or any facilities of a 
nationals securities exchange of, the United States, Canada, Australia or Japan 
or any other jurisdiction if to do so would constitute a violation of the 
relevant laws of such jurisdiction. This announcement does not constitute an 
offer in the United States, Canada, Australia or Japan or any such other 
jurisdiction and the Offer is being  made available by any such use, means, 
instrumentality or facilities or otherwise from or within the United States, 
Canada, Australia or Japan or any such other jurisdiction. Accordingly this 
announcement is not being, and should not be, mailed, transmitted or otherwise 
distributed, in whole or in part, in or into or from the United States, Canada, 
Australia or Japan or any such other jurisdiction. 
 
 
DEALING DISCLOSURE REQUIREMENTS 
 
 
Under the provisions of Rule 8.3 of the Code, if any person is, or becomes, 
"interested" (directly or indirectly) in 1% or more of any class of "relevant 
securities" of Celsis, all "dealings" in any "relevant securities" of that 
company (including by means of an option in respect of, or a derivative 
referenced to, any such "relevant securities") must be publicly disclosed by no 
later than 3.30 pm (London time) on the London business day following the date 
of the relevant transaction. This requirement will continue until the date on 
which the offer becomes, or is declared, unconditional as to acceptances, lapses 
or is otherwise withdrawn or on which the "offer period" otherwise ends. If two 
or more persons act together pursuant to an agreement or understanding, whether 
formal or informal, to acquire an "interest" in "relevant securities" of Celsis, 
they will be deemed to be a single person for the purpose of Rule 8.3. 
 
 
Under the provisions of Rule 8.1 of the Code, all "dealings" in "relevant 
securities" of Celsis by Nastor Holding, Nastor Investments or by any of their 
respective "associates", must be disclosed by not later than 12.00 noon (London 
time) on the London business day following the date of the relevant transaction. 
 
 
A disclosure table, giving details of the companies in whose "relevant 
securities" "dealings" should be disclosed, and the number of such securities in 
issue, can be found on the Panel's website at www.thetakeoverpanel.org.uk. 
 
 
"Interests in securities" arise, in summary, when a person has long economic 
exposure, whether conditional or absolute, to changes in the price of 
securities. In particular, a person will be treated as having an "interest" by 
virtue of the ownership or control of securities, or by virtue of any option in 
respect of, or derivative referenced to, securities. 
 
 
Terms in quotation marks are defined in the Code, which can also be found on the 
Panel's website. If you are in any doubt as to whether or not you are required 
to disclose a "dealing" under Rule 8, you should consult the Panel on telephone 
number +44(0)20 7382 9062 or fax number +44(0)20 7638 1554. 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 OUPCKNKPPBKKFCK 
 

Celadon Pharmaceuticals (LSE:CEL)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Celadon Pharmaceuticals Charts.
Celadon Pharmaceuticals (LSE:CEL)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Celadon Pharmaceuticals Charts.